06855.HK
Ascentage Pharma Group International
HKSE · Healthcare · Biotechnology · CN
HKD 35.00
+1.74%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 8.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 19.21x
- Price / sales
- 10.44x
- Price / cash flow
- -6.81x
Enterprise value
- Enterprise value
- HKD 12.7B
- EV / sales
- 10.64x
- EV / EBITDA
- -4.65x
- EV / EBIT
- -4.35x
- Market cap
- HKD 12.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026